In reversal, US agrees to review new Moderna flu shot
Short excerpt below. Click through to read at the original source.
Vaccine manufacturer Moderna said Wednesday the US Food and Drug Administration walked back its previous position and agreed to review the company’s new mRNA-based flu shot.